The Almonty story has long been a one-act play: tungsten, Chinese export controls, the resurrection of Sangdong, and the West’s desperate scramble for defense supply chains. That narrative has already delivered a 300% share-price surge in twelve months. But the past week has added a second act that most investors have yet to price in. Molybdenum is no longer a sideline curiosity — it is becoming the company’s second strategic pillar, and the timing could hardly be more consequential.
The Offtake That Changes Everything
Almonty has signed an exclusive life-of-mine offtake agreement with SeAH M&S, South Korea’s largest molybdenum processor and the world’s second-largest molybdenum oxide smelter. The floor price is set at $19.00 per pound, before treatment charges, and the expected annual capacity at Sangdong’s molybdenum project is roughly 5,600 tonnes. Based on government historical data, the mine life is estimated at 60 years.
The drilling program to confirm the resource is moving fast. As of June 16, 2026, about 37% of the planned 26 holes — totaling some 12,000 meters — have been completed, and assay grades are matching historical figures. Almonty’s management says it will move straight into production once the resource is verified. That is no small promise, given that South Korea’s government has publicly declared molybdenum supplies critically low and urged private companies to secure their own sources.
Two Catalysts Colliding
The molybdenum breakthrough arrives in the same week that Almonty is set to enter the Russell 1000 and Russell 3000 indices. That inclusion, effective June 29, will trigger automatic buying by passive funds and ETFs — billions of dollars that track these benchmarks. The irony is stark: the stock closed Friday at C$23.26, a 13% weekly drop and a full 30% below its April peak at C$33.35. Those forced buyers will be scooping up shares at a meaningful discount.
The recent decline has a specific culprit. In June, Almonty placed an oversubscribed C$700 million convertible bond — 2.25% coupon, maturing 2031, settled June 9. Arbitrageurs routinely short the underlying equity to hedge such instruments, creating temporary downward pressure. The RSI sits at 41.7, neutral territory, while the 200-day moving average at C$18.04 confirms that the structural re-rating of the past year remains intact.
A Fully Integrated Minerals Platform
Management has branded the combination of Sangdong’s Phase 2 expansion, a planned tungsten oxide plant, and the molybdenum project as the “Korean Trinity” — an end-to-end value chain for strategic minerals that positions South Korea as a global hub for tungsten and molybdenum production and refining.
Should investors sell immediately? Or is it worth buying Almonty?
The tungsten side alone is impressive. Phase 1 is processing roughly 640,000 tonnes of ore per year, yielding about 2,300 tonnes of tungsten concentrate. Phase 2, due online in 2027, will double both figures, and at full capacity Sangdong is expected to supply around 40% of the world’s tungsten demand outside China. That target matters more than ever: Beijing capped tungsten exports to just 15 approved companies late last year, pushing prices to records. Japanese chemical firms Kanto Denka and Central Glass have told customers including Samsung, SK Hynix, and TSMC that they will permanently cease production of tungsten hexafluoride (WF6) from July 2026, a direct consequence of the supply crunch.
The Numbers Beneath the Surface
The financial transformation is real. In the first quarter, revenue surged 221% year-on-year to C$25.4 million, and operating cash flow swung firmly positive to C$9.7 million. The reported net loss is largely an accounting artifact — the strong share-price rally early in the year inflated the value of convertible bonds and derivatives. The market is looking past the bottom line and pricing in the operational turnaround.
Canaccord Genuity analysts project that global tungsten demand could reach 210,000 tonnes by 2035, while non-Chinese supply stagnates under aging mines and declining ore grades. The U.S. has already classified tungsten as a critical mineral with high supply risk, and from January 1, 2027, American defense contractors will be banned from using any tungsten sourced from China, Russia, Iran, or North Korea. That deadline is fast approaching, and Almonty’s acquisition of the Gentung Browns Lake project in the U.S. last year positions it to feed directly into that market.
The Wager Underpinning the Valuation
No one is buying Almonty for current earnings. This is a bet on the West building an independent, secure supply chain for two essential metals — and on South Korea becoming the processing hub for both. The molybdenum offtake agreement and the accelerating drilling program give that bet a second leg that did not exist a few months ago.
There is still risk. The convertible bond structure adds financial complexity. The mine ramp must execute without delays. And if geopolitical tensions ease — if China relaxes export controls — the premium baked into the share price could erode. But for now, the narrative has expanded beyond a single commodity. On June 29, index funds will begin buying a stock that has just added an entire new resource base to its portfolio, at a price 30% below its high. That is a disconnection the market will eventually have to resolve.
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from June 27 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 27.
Almonty: Buy or sell? Read more here...
